arrow
P

Peter St George-Hyslop

columbia university irving medical center
H指数:120
被引数:8.0万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Fibronectin mediates APOE4-driven blood–brain barrier dysfunction in Alzheimer’s disease

纤连蛋白介导APOE4驱动的阿尔茨海默病血脑屏障功能障碍

2026-09-110
OAAI
CD33 and clusterin interact biophysically and genetically to modulate Alzheimer risk

CD33和clusterin通过生物物理和遗传途径相互作用以调节阿尔茨海默病风险

2026-07-170
OAAI
Multiplex neurodegeneration proteotoxicity platform reveals DNAJB6 promotes non-toxic FUS condensate gelation and inhibits neurotoxicity

多通路神经退行性蛋白毒性平台揭示DNAJB6促进非毒性FUS凝聚体凝胶化并抑制神经毒性

2025-11-210
OAAI
HDAC inhibitors engage MITF and the disease-associated microglia signature to enhance amyloid β uptake

HDAC抑制剂通过结合MITF和与疾病相关的微胶质细胞特征来增强β-淀粉样蛋白的摄取

2025-05-300
PRE
Impact of a national dementia research consortium: The Canadian Consortium on Neurodegeneration in Aging (CCNA)

国家痴呆症研究联盟的影响: 加拿大衰老神经变性联盟 (CCNA)

2024-12-051
PRE
Genome-wide analyses reveal a potential role for the MAPT, MOBP, and APOE loci in sporadic frontotemporal dementia

全基因组分析揭示了MAPT,MOBP和APOE基因座在散发性额颞叶痴呆中的潜在作用

2024-07-010
OAAI
The 2022 symposium on dementia and brain aging in low- and middle-income countries: Highlights on research, diagnosis, care, and impact

2022低收入和中等收入国家痴呆症和脑老化研讨会: 研究,诊断,护理和影响的亮点

2024-05-025
OAAI
Asian Cohort for Alzheimer's Disease (ACAD) pilot study on genetic and non-genetic risk factors for Alzheimer's disease among Asian Americans and Canadians

亚洲阿尔茨海默病队列 (ACAD) 亚裔美国人和加拿大人阿尔茨海默病遗传和非遗传危险因素的初步研究

2024-01-126
OAAI
The Nairobi Declaration-Reducing the burden of dementia in low- and middle-income countries (LMICs): Declaration of the 2022 Symposium on Dementia and Brain Aging in LMICs

减少低收入和中等收入国家 (LMICs) 的痴呆症负担: LMICs痴呆和脑老化2022研讨会宣言

2023-03-1111
OA
Biomolecular condensate phase diagrams with a combinatorial microdroplet platform

具有组合微滴平台的生物分子冷凝物相图

2022-12-2122
OAAI